BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31185295)

  • 41. Factor VII deficiency due to compound heterozygosity for Leu-48Pro mutation and a novel Pro260Leu mutation.
    Kogiso N; Taki M; Takamiya O
    Clin Appl Thromb Hemost; 2011; 17(6):E205-10. PubMed ID: 21441234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The paradoxical association between inherited factor VII deficiency and venous thrombosis.
    Marty S; Barro C; Chatelain B; Fimbel B; Tribout B; Reynaud J; Schved JF; Giansily-Blaizot M
    Haemophilia; 2008 May; 14(3):564-70. PubMed ID: 18282149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two novel mutations in severe factor VII deficiency.
    Gomez K; Laffan MA; Kemball-Cook G; Pasi J; Layton M; Singer JD; Tuddenham EG; McVey JH
    Br J Haematol; 2004 Jul; 126(1):105-10. PubMed ID: 15198740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucosidase Inhibition to Study Calnexin-assisted Glycoprotein Folding in Cells.
    Wang H; Wu Q
    Bio Protoc; 2019 Jun; 9(11):. PubMed ID: 31930159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
    Girolami A; Bertozzi I; de Marinis GB; Bonamigo E; Fabris F
    Hematology; 2011 Sep; 16(5):308-12. PubMed ID: 21902896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies.
    Pinotti M; Toso R; Girelli D; Bindini D; Ferraresi P; Papa ML; Corrocher R; Marchetti G; Bernardi F
    Blood; 2000 Jun; 95(11):3423-8. PubMed ID: 10828024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency.
    Rizzotto L; Pinotti M; Pinton P; Rizzuto R; Bernardi F
    Mol Med; 2006; 12(7-8):137-42. PubMed ID: 17088945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asparagine-linked glycosylation of human chymotrypsin C is required for folding and secretion but not for enzyme activity.
    Bence M; Sahin-Tóth M
    FEBS J; 2011 Nov; 278(22):4338-50. PubMed ID: 21920023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3' untranslated region of the factor VII (FVII) gene: molecular characterization of a patient with severe FVII deficiency.
    Peyvandi F; Garagiola I; Palla R; Marziliano N; Mannucci PM
    Hum Mutat; 2005 Nov; 26(5):455-61. PubMed ID: 16173031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.
    Peyvandi F; Jenkins PV; Mannucci PM; Billio A; Zeinali S; Perkins SJ; Perry DJ
    Thromb Haemost; 2000 Aug; 84(2):250-7. PubMed ID: 10959697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct patterns of folding and interactions with calnexin and calreticulin in human class I MHC proteins with altered N-glycosylation.
    Zhang Q; Salter RD
    J Immunol; 1998 Jan; 160(2):831-7. PubMed ID: 9551918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two double heterozygous mutations in the F7 gene show different manifestations.
    Nagaizumi K; Inaba H; Suzuki T; Hatta Y; Hagiwara T; Amano K; Arai M; Fukutake K
    Br J Haematol; 2002 Dec; 119(4):1052-8. PubMed ID: 12472587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inherited factor VII deficiency: identification of two novel mutations (A191V and T239P) in the catalytic domain.
    Borensztajn K; Chafa O; Le Bonniec B; Wajcman H; Reghis A; Fischer AM; Tapon-Bretaudière J
    Thromb Res; 2005; 116(2):115-20. PubMed ID: 15907525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity.
    Preisler B; Pezeshkpoor B; Merzenich A; Ohlenforst S; Rühl H; Ivaškevičius V; Scholz U; Bönigk H; Eberl W; Zieger B; Pavlova A; Oldenburg J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency.
    Peyvandi F; De Cristofaro R; Garagiola I; Palla R; Akhavan S; Landolfi R; Mannucci PM
    Br J Haematol; 2004 Dec; 127(5):576-84. PubMed ID: 15566361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome.
    Serrano-Perez MC; Tilley FC; Nevo F; Arrondel C; Sbissa S; Martin G; Tory K; Antignac C; Mollet G
    J Biol Chem; 2018 Mar; 293(11):4122-4133. PubMed ID: 29382718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients.
    Fromovich-Amit Y; Zivelin A; Rosenberg N; Tamary H; Landau M; Seligsohn U
    J Thromb Haemost; 2004 Oct; 2(10):1774-81. PubMed ID: 15456489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of a Cys329Gly mutation causing hereditary factor VII deficiency.
    Wu Y; Tu X; Lian Y; Chen F; Lan F; Zhu Z
    Acta Haematol; 2006; 116(2):96-100. PubMed ID: 16914903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of N-glycan precursor length diversity on quality control of protein folding and on protein glycosylation.
    Samuelson J; Robbins PW
    Semin Cell Dev Biol; 2015 May; 41():121-8. PubMed ID: 25475176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule.
    Arbini AA; Mannucci M; Bauer KA
    Blood; 1996 Jun; 87(12):5085-94. PubMed ID: 8652821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.